Organon OGN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.12B+94.4% | $574M-14.6% | $672M+12.2% | $599M+9.5% | $547M-19.0% | ||
| $1.38B+4.0% | $1.33B-10.3% | $1.48B0.0% | $1.48B+1.9% | $1.46B+7.3% | ||
| $252M+6.8% | $236M-4.5% | $247M+2.9% | $240M+15.9% | $207M-3.7% | ||
| $4.93B+13.3% | $4.35B-7.4% | $4.7B+1.8% | $4.62B+5.7% | $4.37B+0.5% | ||
| $1.28B-1.8% | $1.3B+1.0% | $1.29B+1.9% | $1.27B+5.8% | $1.2B+2.5% | ||
| $4.15B0.0% | $4.15B-11.3% | $4.68B0.0% | $4.68B0.0% | $4.68B0.0% | ||
| $1.1B-2.7% | $1.13B-15.7% | $1.34B-1.6% | $1.36B-3.9% | $1.42B+0.2% | ||
| $13B+1.0% | $12.87B-5.1% | $13.55B+0.4% | $13.5B+2.6% | $13.16B+0.4% | ||
| $983M+3.3% | $952M-11.4% | $1.07B+0.7% | $1.07B+6.1% | $1.01B-12.7% | ||
| $16M0.0% | $16M-64.4% | $45M-60.9% | $115M+475% | $20M0.0% | ||
| $2.5B+4.6% | $2.39B-10.8% | $2.68B-4.2% | $2.8B+6.9% | $2.62B-3.8% | ||
| $8.55B-0.9% | $8.63B-1.8% | $8.78B0.0% | $8.78B-1.7% | $8.94B+0.9% | ||
| $12.09B-0.2% | $12.12B-4.2% | $12.65B-0.9% | $12.77B+1.2% | $12.61B-0.1% | ||
| 500M0.0% | 500M0.0% | 500M0.0% | 500M0.0% | 500M+16,567% | ||
| $1.25B+13.0% | $1.11B-15.9% | $1.32B+13.3% | $1.16B+13.4% | $1.03B+1.6% | ||
| $903M+20.1% | $752M-17.0% | $906M+23.6% | $733M+35.2% | $542M+14.8% | ||
| $13B+1.0% | $12.87B-5.1% | $13.55B+0.4% | $13.5B+2.6% | $13.16B+0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Organon cover its short-term obligations?
- Its current ratio is 1.97 — current assets exceed current liabilities.
- Where does Organon's balance sheet data come from?
- Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.